Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10089210 | 1.00 | SLC6A4 (0.33) | SLC6A4SLC6A3 | |
| SCHEMBL5868545 | 0.84 | SLC6A4 (0.35) | SLC6A4SLC6A3 | |
| SCHEMBL13069780 | 0.81 | — | — | |
| SCHEMBL286847 | 0.77 | — | — | |
| SCHEMBL9064747 | 0.77 | — | — | |
| SCHEMBL27439110 | 0.77 | — | — | |
| SCHEMBL13515554 | 0.77 | — | — | |
| SCHEMBL25910376 | 0.77 | SLC6A4 (0.33) | SLC6A4SLC6A3 | |
| SCHEMBL2776656 | 0.74 | SLC6A4 (0.32) | SLC6A4SLC6A3 | |
| SCHEMBL17490376 | 0.74 | SLC6A4 (0.32) | SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7560598-B2 | reacting a saturated, tertiary terpene alcohol with hypochloric acid under conditions effective to produce at least one oxidation product selected from the group consisting of cyclic ethers, chloroketones, and mixtures thereof | MILLENNIUM SPECIALTY CHEMICALS, INC. (US) | 2009-07-14 | — | — | US | claimed |
| US-20070238629-A1 | Fragrance compositions from tertiary terpene alcohols | RENESSENZ LLC | 2007-10-11 | — | — | US | claimed |
| EP-0638591-B1 | Copolymers containing hydroxyl groups, their preparation and their use in high solids coatings | HOECHST AG (DE) | 1998-01-28 | — | — | EP | claimed |
| CN-112574015-B | Method for preparing cyclocitral from C10 unsaturated aldehyde rectifying tower bottoms | 万华化学集团股份有限公司 | 2022-09-20 | — | — | CN | disclosed |
| EP-3174877-B1 | INDOLIZINE DERIVATIVES WHICH ARE APPLICABLE TO NEURODEGENERATIVE DISEASES | MERCK PATENT GMBH (DE) | 2022-06-29 | — | — | EP | disclosed |
| US-10889901-B2 | Ultraviolet-stabilized corrosion inhibitors | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-01-12 | — | — | US | disclosed |
| US-20200032401-A1 | ULTRAVIOLET-STABILIZED CORROSION INHIBITORS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2020-01-30 | — | — | US | disclosed |
| US-9809521-B2 | Cannabidinoid derivatives | SUTTER WEST BAY HOSPITALS (US) | 2017-11-07 | — | — | US | disclosed |
| US-20170079965-A1 | NOVEL INDOLIZINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| US-9546166-B2 | Indolizine derivatives and their use in neurodegenerative diseases | MERCK PATENT GMBH (DE) | 2017-01-17 | — | — | US | disclosed |
| WO-2016019228-A1 | INDOLIZINE DERIVATIVES WHICH ARE APPLICABLE TO NEURODEGENERATIVE DISEASES | MERCK PATENT GMBH (DE) | 2016-02-04 | — | — | WO | disclosed |
| US-20070238629-A1 | Fragrance compositions from tertiary terpene alcohols | RENESSENZ LLC | 2007-10-11 | — | — | US | disclosed |
| US-20070238629-A1 | Fragrance compositions from tertiary terpene alcohols | RENESSENZ LLC | 2007-10-11 | — | — | US | disclosed |
| US-20070238629-A1 | Fragrance compositions from tertiary terpene alcohols | RENESSENZ LLC | 2007-10-11 | — | — | US | disclosed |
| US-7179800-B2 | Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-02-20 | — | — | US | disclosed |
| US-7179800-B2 | Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-02-20 | — | — | US | disclosed |
| US-20070037890-A1 | Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-02-15 | — | — | US | disclosed |
| US-20070037890-A1 | Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2007-02-15 | — | — | US | disclosed |
| WO-2006119504-A2 | FUSED HETEROCYCLIC COMPOUNDS, AND COMPOSITIONS AND USES THEREOF | RENOVIS, INC. (US) | 2006-11-09 | — | — | WO | disclosed |
| US-20060217448-A1 | e.g. 4-benzyl-N-[2-(2-chlorophenyl)ethyl]-4,7,9-triazabicyclo[4.4.0]deca-7,9,11-triene-10-carboxamide; antiinflammatory and analgesic agent; rheumatoid arthritis, osteoarthritis, Parkinson's disease, uveitis, asthma, cardiovascular conditions, myocardial infarction | RENOVIS, INC. | 2006-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10889901-B2 | Ultraviolet-stabilized corrosion inhibitors | TYR, UNG, MGMT | SLC6A4 2846/4885SLC6A3 3385/4885 |
| US-20200032401-A1 | ULTRAVIOLET-STABILIZED CORROSION INHIBITORS | TYR, UNG, MGMT | SLC6A4 2846/4885SLC6A3 3385/4885 |
| US-20060217448-A1 | e.g. 4-benzyl-N-[2-(2-chlorophenyl)ethyl]-4,7,9-triazabicyclo[4.4.0]deca-7,9,11-triene-10-carboxamide; antiinflammatory and analgesic agent; rheumatoid arthritis, osteoarthritis, Parkinson's disease, uveitis, asthma, cardiovascular conditions, myocardial infarction | PARK7, UACA, PTGER4 | SLC6A4 4573/4885SLC6A3 4318/4885 |
| US-20170079965-A1 | NOVEL INDOLIZINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES | P2RX5, P2RX4, P2RX3 | SLC6A4 108/4885SLC6A3 171/4885 |
| US-20070037890-A1 | Such as 2-(3-methylcyclohexyl)-5-(1,1'-dimethylheptyl)-resorcinol for treatment of pain, inflammation and autoimmune disease | CNR1, CNR2, HRH4 | SLC6A4 2648/4885SLC6A3 2760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.